168 related articles for article (PubMed ID: 30878315)
1. Overall Survival Trends and Clinical Characteristics of Plasmacytoma in the United States: A National Cancer Database Analysis.
Ghiassi-Nejad Z; Ru M; Moshier E; Chang S; Jagannath S; Dharmarajan K
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):310-319. PubMed ID: 30878315
[TBL] [Abstract][Full Text] [Related]
2. Epidemiologic evidence of superior outcomes for extramedullary plasmacytoma of the head and neck.
Gerry D; Lentsch EJ
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):974-81. PubMed ID: 23482476
[TBL] [Abstract][Full Text] [Related]
3. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
4. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA.
Thumallapally N; Meshref A; Mousa M; Terjanian T
BMC Cancer; 2017 Jan; 17(1):13. PubMed ID: 28056880
[TBL] [Abstract][Full Text] [Related]
5. Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: A population-based study.
Shen X; Liu S; Wu C; Wang J; Li J; Chen L
Cancer Med; 2021 Jan; 10(2):462-470. PubMed ID: 33145987
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and prognostic factors in solitary plasmacytoma.
Finsinger P; Grammatico S; Chisini M; Piciocchi A; Foà R; Petrucci MT
Br J Haematol; 2016 Feb; 172(4):554-60. PubMed ID: 26684545
[TBL] [Abstract][Full Text] [Related]
7. Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.
Shin HJ; Kim K; Lee JW; Song MK; Lee JJ; Lee HS; Lee WS; Kim SJ; Chung JS
Eur J Haematol; 2014 Nov; 93(5):414-21. PubMed ID: 24813053
[TBL] [Abstract][Full Text] [Related]
8. Skeletal Plasmacytoma: progression of disease and impact of local treatment; an analysis of SEER database.
Jawad MU; Scully SP
J Hematol Oncol; 2009 Sep; 2():41. PubMed ID: 19778427
[TBL] [Abstract][Full Text] [Related]
9. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone.
Shih LY; Dunn P; Leung WM; Chen WJ; Wang PN
Br J Cancer; 1995 Jan; 71(1):128-33. PubMed ID: 7819027
[TBL] [Abstract][Full Text] [Related]
10. Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.
Rosenberg AS; Ruthazer R; Paulus JK; Kent DM; Evens AM; Klein AK
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):684-692.e3. PubMed ID: 27771291
[TBL] [Abstract][Full Text] [Related]
11. Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas.
Penumarthy NL; Goldsby RE; Shiboski SC; Wustrack R; Murphy P; Winestone LE
Cancer Med; 2020 Feb; 9(3):951-958. PubMed ID: 31838786
[TBL] [Abstract][Full Text] [Related]
12. Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset.
Goyal G; Bartley AC; Funni S; Inselman J; Shah ND; Marshall AL; Ashrani AA; Kapoor P; Durani U; Hashmi SK; Siddiqui MA; Buadi FK; Go RS; Kyle RA; Kumar S; Gonsalves WI
Leukemia; 2018 Jun; 32(6):1414-1420. PubMed ID: 29654264
[TBL] [Abstract][Full Text] [Related]
13. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA
Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085
[TBL] [Abstract][Full Text] [Related]
14. Our experience of solitary plasmacytoma of the bone: improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy.
Le Ray E; Belin L; Plancher C; Anract P; Babinet A; Dumaine V; Tamburini J; Deau Fischer B; Willems L; Magro L; Facon T; Leleu X; Bouscary D; Kirova YM
Leuk Lymphoma; 2018 Jul; 59(7):1756-1758. PubMed ID: 29087212
[No Abstract] [Full Text] [Related]
15. Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience.
Alghisi A; Borghetti P; Maddalo M; Roccaro AM; Tucci A; Mazzola R; Magrini SM; Lo Casto A; Bonù ML; Tomasini D; Pasinetti N; Peretto G; Bertagna F; Tomasi C; Buglione M; Triggiani L
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1773-1779. PubMed ID: 33201300
[TBL] [Abstract][Full Text] [Related]
16. Solitary bone plasmacytoma and extramedullary plasmacytoma.
Dimopoulos MA; Hamilos G
Curr Treat Options Oncol; 2002 Jun; 3(3):255-9. PubMed ID: 12057071
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract][Full Text] [Related]
18. Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma.
Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
Am J Hematol; 2016 May; 91(5):476-80. PubMed ID: 26852276
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Plasma Cell Neoplasms: A Population-Based Study.
Loap P; Vignon M; Bouscary D; Kirova Y
Clin Lymphoma Myeloma Leuk; 2022 Nov; 22(11):841-846. PubMed ID: 35941071
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of solitary plasmacytoma].
Brinch L; Hannisdal E; Abrahamsen AF; Kvaløy S; Langholm R
Tidsskr Nor Laegeforen; 1990 May; 110(12):1515-6. PubMed ID: 2339400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]